# Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine

> **NCT00880373** · PHASE4 · TERMINATED · sponsor: **London North West Healthcare NHS Trust** · enrollment: 320 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Placebo
- **DRUG:** Diamorphine or Morphine

## Key facts

- **NCT ID:** NCT00880373
- **Lead sponsor:** London North West Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-08
- **Target enrollment:** 320 (ESTIMATED)
- **Why stopped:** The funding withdrawal and early termination of the trial is based upon lack of suitable recruitment figures in order to reach the required trial endpoints.
- **Last updated:** 2012-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880373, "Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00880373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*